Literature DB >> 10614617

Vitamin D and prostate cancer.

D Feldman, X Y Zhao, A V Krishnan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10614617     DOI： 10.1210/endo.141.1.7341

Source DB:  PubMed          Journal:  Endocrinology        ISSN： 0013-7227            Impact factor:   4.736


× No keyword cloud information.
  12 in total

1.  Vitamin d for the management of prostate cancer.

Authors:  Masood A Khan; Alan W Partin
Journal:  Rev Urol       Date:  2004

Review 2.  The vitamin D deficiency pandemic and consequences for nonskeletal health: mechanisms of action.

Authors:  Michael F Holick
Journal:  Mol Aspects Med       Date:  2008-09-02

3.  Associations Between Serum Vitamin D and Adverse Pathology in Men Undergoing Radical Prostatectomy.

Authors:  Yaw A Nyame; Adam B Murphy; Diana K Bowen; Gregory Jordan; Ken Batai; Michael Dixon; Courtney M P Hollowell; Stephanie Kielb; Joshua J Meeks; Peter H Gann; Virgilia Macias; Andre Kajdacsy-Balla; William J Catalona; Rick Kittles
Journal:  J Clin Oncol       Date:  2016-02-22       Impact factor: 44.544

4.  Dexamethasone enhances 1alpha,25-dihydroxyvitamin D3 effects by increasing vitamin D receptor transcription.

Authors:  Alejandro A Hidalgo; Kristin K Deeb; J Wesley Pike; Candace S Johnson; Donald L Trump
Journal:  J Biol Chem       Date:  2011-08-25       Impact factor: 5.157

Review 5.  Resurrection of vitamin D deficiency and rickets.

Authors:  Michael F Holick
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

Review 6.  Role of androgen and vitamin D receptors in endothelial cells from benign and malignant human prostate.

Authors:  Alejandro S Godoy; Ivy Chung; Viviana P Montecinos; Ralph Buttyan; Candace S Johnson; Gary J Smith
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-04-02       Impact factor: 4.310

7.  Diabetes and the vitamin d connection.

Authors:  Michael F Holick
Journal:  Curr Diab Rep       Date:  2008-10       Impact factor: 4.810

8.  1Alpha,25-dihydroxyvitamin D3 reduces c-Myc expression, inhibiting proliferation and causing G1 accumulation in C4-2 prostate cancer cells.

Authors:  JoyAnn N Phillips Rohan; Nancy L Weigel
Journal:  Endocrinology       Date:  2009-01-22       Impact factor: 4.736

9.  Prognostic effects of 25-hydroxyvitamin D levels in gastric cancer.

Authors:  Chao Ren; Miao-zhen Qiu; De-shen Wang; Hui-yan Luo; Dong-sheng Zhang; Zhi-qiang Wang; Feng-hua Wang; Yu-hong Li; Zhi-wei Zhou; Rui-hua Xu
Journal:  J Transl Med       Date:  2012-01-27       Impact factor: 5.531

10.  Retinoids regulate the formation and degradation of gap junctions in androgen-responsive human prostate cancer cells.

Authors:  Linda Kelsey; Parul Katoch; Kristen E Johnson; Surinder K Batra; Parmender P Mehta
Journal:  PLoS One       Date:  2012-04-13       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.